Violeta Martínez‐Robles

Instituto de Salud Carlos III — Spain

Medicine · Health Sciences

11h-index515citations23works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(13), Blood groups and transfusion(9), Blood properties and coagulation(5), Acute Myeloid Leukemia Research(4), Chronic Lymphocytic Leukemia Research(4)

Publications21 total

Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency
Thrombosis and Haemostasis·2025Open Access
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Blood·2024· 23 cited
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine·2023· 28 citedOpen Access
Recommendations for the Clinical Approach to Primary Immune Thrombocytopenia
Preprints.org·2023· 1 citedOpen Access
Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies
Journal of Personalized Medicine·2020· 1 citedOpen Access
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal Of Haematology·2019· 12 citedOpen Access
Treatment of acquired haemophilia in the elderly. Study of 10 cases
Medicina Clínica (English Edition)·2018
Tratamiento de la hemofilia adquirida en el paciente anciano. Estudio de 10 casos
Medicina Clínica·2018· 2 cited
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)
Leukemia & lymphoma/Leukemia and lymphoma·2017· 25 cited
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
International Journal of Hematology·2017· 52 cited
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice
British Journal of Haematology·2017· 35 citedOpen Access
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal Of Haematology·2015· 49 citedOpen Access
Azacitidine in Older Patients with Acute Myeloid Leukemia (AML). Results from the Expanded International E-Alma Series (E-ALMA+) According to the MRC Risk Index Score
Blood·2015· 2 cited
Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice
Blood·2015
Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP
Blood·2015· 1 cited
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
British Journal of Haematology·2014· 77 citedOpen Access
Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia
Blood·2014· 28 cited
Use of Eltrombopag after Romiplostim in Primary ITP Patients
Blood·2014· 1 cited
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology·2014· 148 citedOpen Access
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes
Leukemia & lymphoma/Leukemia and lymphoma·2013· 18 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Cristina Pascual(12), Blanca Sánchez‐González(12), María Román(11), Silvia Bernat(11), Pável Olivera(10), José‐Ángel Hernández‐Rivas(9), Gloria Pérez‐Rus(9), José Ramón González‐Porras(9), Isidro Jarque(8), Marta Gómez‐Núñez(8), Angeles Fernández‐Rodríguez(8), María Jesús Peñarrubia(8), Tomás José González‐López(8), Isabel Caparrós(7), María Eva Mingot‐Castellano(7), Montserrat Cortés(7), Carmen Fernández‐Miñano(7), Erik de Cabo(7), Javier García‐Frade(7), Marcio Andrade(6)